NeuroLux has launched the first commercially manufactured Optofluidics device, providing drug delivery and optogenetics modalities. It is an implantable, lightweight, battery-free device with parameter control on the individual device level. The device combines soft microfluidic and microscale inorganic light-emitting diode probes for programmable pharmacology and optogenetics, designed to offer the features...
NeuroLux Remote Workshop
NeuroLux is extending its reach to China as the global provider of breakthrough technologies for optogenetics. Its first international remote workshop invites the neuroscience community across China to get familiar with the NeuroLux system, devices and to interact with engineers behind the technology. Event Details: Platform: Zoom Date: August 11,...
Tuning Made Easy: NeuroLux Launches the Autotuner
NeuroLux has launched the Autotuner, an upgrade to the manual Antenna Tuner Box which matches the impedance of the source and the antenna. This step is crucial to the overall performance of the NeuroLux system, with accurate tuning corresponding to maximized power transfer to the implantable devices in any antenna...
NeuroLux to Attend the 2019 Materials Research Society Spring Meeting and Exhibit
Come out to Phoenix, Arizona to attend the 2019 Materials Research Society Spring Meeting and Exhibit, where interdisciplinary researchers worldwide come to network and exchange knowledge. There will be seven different symposium sessions, ranging from topics on colloidal nanoparticles to In Situ experimentation and techniques. Join our CEO, Tony Banks,...